NCT03929029 2026-01-05Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced MelanomaDana-Farber Cancer InstitutePhase 1 Active not recruiting11 enrolled 11 charts